tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FATE Stock Latest News

Is FATE a Buy, Before Earnings?
Pre-EarningsIs FATE a Buy, Before Earnings?
12d ago
FATE
Fate Therapeutics Strengthens Legal Safeguards for Leadership
PremiumCompany Announcements
Fate Therapeutics Strengthens Legal Safeguards for Leadership
2M ago
8K
FATE
Fate Therapeutics reports Q2 EPS (33c), consensus (47c)
PremiumThe Fly
Fate Therapeutics reports Q2 EPS (33c), consensus (47c)
3M ago
FATE
Fate Therapeutics Appoints AI Expert to Enhance Board
PremiumCompany Announcements
Fate Therapeutics Appoints AI Expert to Enhance Board
3M ago
8K
FATE
Fate Therapeutics appoints Neely Mozaffarian to board of directors
PremiumThe Fly
Fate Therapeutics appoints Neely Mozaffarian to board of directors
3M ago
FATE
FATE Earnings this Week: How Will it Perform?
PremiumPre-EarningsFATE Earnings this Week: How Will it Perform?
3M ago
FATE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ADVM
ALLO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ABIO
ALLO
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
PremiumThe Fly
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
5M ago
FATE
NTLA
Fate Therapeutics upgraded to Overweight from Neutral at Piper Sandler
PremiumThe Fly
Fate Therapeutics upgraded to Overweight from Neutral at Piper Sandler
5M ago
FATE
Fate Therapeutics Announces CFO Change and Shareholder Approvals
PremiumCompany Announcements
Fate Therapeutics Announces CFO Change and Shareholder Approvals
5M ago
8K
FATE
Fate Therapeutics CFO Resigns, CEO to Assume Role
PremiumCompany Announcements
Fate Therapeutics CFO Resigns, CEO to Assume Role
5M ago
8K
FATE
Fate Therapeutics CFO Dulac resigns
PremiumThe FlyFate Therapeutics CFO Dulac resigns
5M ago
FATE
Fate Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
Premium
The Fly
Fate Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
6M ago
FATE
Fate Therapeutics’ Reporting Strategy: A Double-Edged Sword for Investor Confidence and Share Stability
Premium
Company Announcements
Fate Therapeutics’ Reporting Strategy: A Double-Edged Sword for Investor Confidence and Share Stability
6M ago
FATE
Fate Therapeutics price target lowered to $4 from $7 at Piper Sandler
PremiumThe Fly
Fate Therapeutics price target lowered to $4 from $7 at Piper Sandler
6M ago
FATE
Fate Therapeutics price target lowered to $5 from $7 at Wedbush
PremiumThe Fly
Fate Therapeutics price target lowered to $5 from $7 at Wedbush
6M ago
FATE
Fate Therapeutics price target lowered to $9 from $11 at Canaccord
PremiumThe Fly
Fate Therapeutics price target lowered to $9 from $11 at Canaccord
6M ago
FATE
Fate Therapeutics reports Q1 EPS (47c), consensus (49c)
PremiumThe Fly
Fate Therapeutics reports Q1 EPS (47c), consensus (49c)
6M ago
FATE
Fate Therapeutics Advances in Autoimmune and Cancer Therapies
PremiumCompany AnnouncementsFate Therapeutics Advances in Autoimmune and Cancer Therapies
6M ago
8K
FATE
Fate Therapeutics announces first lupus patient treated in Phase 1 FT819 trial
Premium
The Fly
Fate Therapeutics announces first lupus patient treated in Phase 1 FT819 trial
6M ago
FATE
FATE Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
FATE Earnings this Week: How Will it Perform?
6M ago
FATE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >